Bleomycin induces cellular senescence in alveolar epithelial cells

Area of Science:

• Cell Biology
• Pulmonary Medicine
• Toxicology

Background:

• Cellular senescence is a fundamental biological process characterized by irreversible growth arrest.
• Pulmonary fibrosis is a progressive lung disease often associated with impaired tissue repair and epithelial cell dysfunction.
• Bleomycin is a chemotherapeutic agent known to induce lung injury and fibrosis.

Purpose of the Study:

• To investigate whether bleomycin induces cellular senescence in alveolar epithelial cells.
• To characterize the specific markers of senescence induced by bleomycin in vitro and in vivo.
• To explore the potential role of bleomycin-induced epithelial senescence in the pathogenesis of pulmonary fibrosis.

Main Methods:

• Exposure of A549 cells and primary rat type II alveolar epithelial cells to bleomycin.
• Evaluation of senescence markers including senescence-associated beta-galactosidase (SA-β-gal) activity, cell morphology, cell size, lysosomal mass, p21 protein expression, and growth arrest.
• Intratracheal administration of bleomycin in C57BL/6 mice, followed by SA-β-gal activity assessment in lung tissue.

Main Results:

• Bleomycin exposure induced a dose- and time-dependent increase in SA-β-gal activity, altered cell morphology, increased cell size and lysosomal mass, and p21 overexpression in alveolar epithelial cells.
• Bleomycin treatment resulted in irreversible growth arrest of the treated cells.
• Intratracheal bleomycin administration in mice led to increased SA-β-gal activity in type II epithelial cells, peaking at day 7.

Conclusions:

• Bleomycin induces a cellular phenotype in alveolar epithelial cells that is indistinguishable from senescence.
• The induction of epithelial senescence by bleomycin may be a key factor in the impaired re-epithelialisation process observed in bleomycin-induced pulmonary fibrosis.
• These findings highlight a novel mechanism by which bleomycin may contribute to lung fibrogenesis.